<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36707813</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1755-8794</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC medical genomics</Title><ISOAbbreviation>BMC Med Genomics</ISOAbbreviation></Journal><ArticleTitle>Three nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis.</ArticleTitle><Pagination><StartPage>15</StartPage><MedlinePgn>15</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12920-023-01441-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease in adults. However, ALS, especially sporadic ALS (sALS), is difficult to diagnose due to the lack of biomarkers.</AbstractText><AbstractText Label="RESULTS">We used the bioinformatics technology to find the potential biomarker and we found that two hundred seventy-four DEGs were identified and enrichment analysis showed DEGs were involved in nervous system activity, like axon_guidance and the neurotrophin_signaling_pathway. Five nervous system-specific expressed hub genes were further validated by three GEO datasets. APP, LRRK2, and PSEN1 might be potential diagnostic and prognostic biomarkers of sALS, and NEAT1-miR-373-3p/miR-302c-3p/miR-372-3p-APP, circ_0000002-miR-302d-3p/miR-373-3p-APP and XIST-miR-9-5p/miR-30e-5p/miR-671-5p might be potential ceRNA regulatory pathways. APP SNP analysis showed subjects harboring the minor G allele of rs463946, minor G allele of rs466433 and minor C allele of rs364048 had an increased risk of sALS development.</AbstractText><AbstractText Label="CONCLUSIONS">Our results identified three nervous system-specific expressed hub genes that might be diagnostic and prognostic markers of sALS and APP might be a genetic susceptibility factor contributing to sALS development.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liao</LastName><ForeName>Yifu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cai</LastName><ForeName>Haiping</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Luo</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dongcheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Maoming People's Hospital, Maoming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Geng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Maoming People's Hospital, Maoming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Jinhai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Eastern Department of Neurology, Guangdong Geriatrics Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. duanjh888@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Clinical College of Nanchang Medical College, Nanchang, China. xurenshi@ncu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Maoming People's Hospital, Maoming, China. xiong715@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81960244</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2019A1515011341</GrantID><Agency>Natural Science Foundation of Guangdong Province of China</Agency><Country/></Grant><Grant><GrantID>81360198</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Genomics</MedlineTA><NlmUniqueID>101319628</NlmUniqueID><ISSNLinking>1755-8794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatic analysis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Competitive endogenous RNA</Keyword><Keyword MajorTopicYN="N">Single nucleotide polymorphism</Keyword><Keyword MajorTopicYN="N">Sporadic amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>0</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36707813</ArticleId><ArticleId IdType="pmc">PMC9881351</ArticleId><ArticleId IdType="doi">10.1186/s12920-023-01441-x</ArticleId><ArticleId IdType="pii">10.1186/s12920-023-01441-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Le Bras A. New insights into C9ORF72-ALS/FTD using C. elegans. Lab Anim. 2022;51(1):8. doi: 10.1038/s41684-021-00903-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41684-021-00903-y</ArticleId><ArticleId IdType="pubmed">34949851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ustyantseva EI, Medvedev SP, Zakian SM. Studying ALS: current approaches, effect on potential treatment strategy. Adv Exp Med Biol. 2020;1241:195&#x2013;217. doi: 10.1007/978-3-030-41283-8_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-41283-8_11</ArticleId><ArticleId IdType="pubmed">32383122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagnostics. 2021;11(4):624. doi: 10.3390/diagnostics11040624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11040624</ArticleId><ArticleId IdType="pmc">PMC8065866</ArticleId><ArticleId IdType="pubmed">33808458</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmadasa T, Kiernan MC. Riluzole, disease stage and survival in ALS. Lancet Neurol. 2018;17(5):385&#x2013;386. doi: 10.1016/S1474-4422(18)30091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30091-7</ArticleId><ArticleId IdType="pubmed">29525493</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JM, Kim SY, Park D, Park JS. Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2020;41(1):119&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223963</ArticleId><ArticleId IdType="pubmed">31471712</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, De Calbiac H, Kabashi E, Barmada SJ. Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy. 2022;18(2):254&#x2013;282. doi: 10.1080/15548627.2021.1926656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1926656</ArticleId><ArticleId IdType="pmc">PMC8942428</ArticleId><ArticleId IdType="pubmed">34057020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1&#x2013;2 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Kumar MS, Ramesh N, Anderson EN, Nguyen AT, Kim B, et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat Neurosci. 2021;24(8):1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Qiu W, Hu F, Zhang X, Deng Y, Nie H, et al. The rs2619566, rs10260404, and rs79609816 polymorphisms are associated with sporadic amyotrophic lateral sclerosis in individuals of Han Ancestry from Mainland China. Front Genet. 2021;12:679204. doi: 10.3389/fgene.2021.679204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.679204</ArticleId><ArticleId IdType="pmc">PMC8378233</ArticleId><ArticleId IdType="pubmed">34421992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson KM, Katona E, Glaria I, Carcole M, Swift IJ, Sogorb-Esteve A, et al. Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2022;93:761&#x2013;771. doi: 10.1136/jnnp-2021-328710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-328710</ArticleId><ArticleId IdType="pmc">PMC9279742</ArticleId><ArticleId IdType="pubmed">35379698</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garcia L, Lopez-Royo T, Calvo AC, Toivonen JM, de la Torre M, Moreno-Martinez L, et al. Competing endogenous RNA networks as biomarkers in neurodegenerative diseases. Int J Mol Sci. 2020;21(24):9582. doi: 10.3390/ijms21249582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249582</ArticleId><ArticleId IdType="pmc">PMC7765627</ArticleId><ArticleId IdType="pubmed">33339180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazarov PV, Kreis S. Integrative approaches for analysis of mRNA and microRNA high-throughput data. Comput Struct Biotechnol J. 2021;19:1154&#x2013;1162. doi: 10.1016/j.csbj.2021.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.029</ArticleId><ArticleId IdType="pmc">PMC7895676</ArticleId><ArticleId IdType="pubmed">33680358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N, Liu K, Yang M, Gao X. ceRNAs in cancer: mechanism and functions in a comprehensive regulatory network. J Oncol. 2021;2021:4279039. doi: 10.1155/2021/4279039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/4279039</ArticleId><ArticleId IdType="pmc">PMC8516523</ArticleId><ArticleId IdType="pubmed">34659409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910&#x2013;928. doi: 10.1016/j.csbj.2021.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.01.018</ArticleId><ArticleId IdType="pmc">PMC7851342</ArticleId><ArticleId IdType="pubmed">33598105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani SS, Ebrahimi R, Al EAA, Panahi G, Meshkani R, Younesi S, et al. Competing endogenous RNAs (CeRNAs): novel network in neurological disorders. Curr Med Chem. 2021;28(29):5983&#x2013;6010. doi: 10.2174/0929867328666201217141837.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867328666201217141837</ArticleId><ArticleId IdType="pubmed">33334276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2022;51:D587&#x2013;D592. doi: 10.1093/nar/gkac963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac963</ArticleId><ArticleId IdType="pmc">PMC9825424</ArticleId><ArticleId IdType="pubmed">36300620</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Debska-Vielhaber G, Miller I, Peeva V, Zuschratter W, Walczak J, Schreiber S, et al. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers. Exp Neurol. 2021;339:113620. doi: 10.1016/j.expneurol.2021.113620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113620</ArticleId><ArticleId IdType="pubmed">33497646</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M. Chitinases, neuroinflammation and biomarkers in ALS. J Neurol Neurosurg Psychiatry. 2020;91(4):338. doi: 10.1136/jnnp-2019-322520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322520</ArticleId><ArticleId IdType="pubmed">31937583</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 2018;41(9):587&#x2013;598. doi: 10.1016/j.tins.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC6174532</ArticleId><ArticleId IdType="pubmed">29885742</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent P, Booth L, Roberts JL, Poklepovic A, Cridebring D, Reiman EM. Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43. Aging. 2021;13(13):17097&#x2013;17117. doi: 10.18632/aging.203297.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203297</ArticleId><ArticleId IdType="pmc">PMC8312464</ArticleId><ArticleId IdType="pubmed">34252884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson JB, Hobbs C, Parsons MJ, Bosch KD, Pandraud A, Walsh FS, et al. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3871&#x2013;3882. doi: 10.1093/hmg/dds215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds215</ArticleId><ArticleId IdType="pubmed">22678056</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanga S, Brambilla L, Tasiaux B, Dang AH, Ivanoiu A, Octave JN, et al. A role for GDNF and soluble APP as biomarkers of amyotrophic lateral sclerosis pathophysiology. Front Neurol. 2018;9:384. doi: 10.3389/fneur.2018.00384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00384</ArticleId><ArticleId IdType="pmc">PMC5988896</ArticleId><ArticleId IdType="pubmed">29899726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye LQ, Li XY, Zhang YB, Cheng HR, Ma Y, Chen DF, et al. The discriminative capacity of CSF beta-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population. J Neurol Sci. 2020;412:116756. doi: 10.1016/j.jns.2020.116756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116756</ArticleId><ArticleId IdType="pubmed">32142967</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39(1):73&#x2013;82. doi: 10.1080/01616412.2016.1251711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2016.1251711</ArticleId><ArticleId IdType="pubmed">27809706</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadoni O, Crestini A, Piscopo P, Malvezzi-Campeggi L, Carunchio I, Pieri M, et al. Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells. Cell Mol Neurobiol. 2009;29(5):635&#x2013;641. doi: 10.1007/s10571-009-9356-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9356-8</ArticleId><ArticleId IdType="pubmed">19214738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, et al. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease. Nat Commun. 2022;13(1):159. doi: 10.1038/s41467-021-27572-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27572-2</ArticleId><ArticleId IdType="pmc">PMC8748865</ArticleId><ArticleId IdType="pubmed">35013160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Chopra N, Nho K, Maloney B, Obukhov AG, Nelson PT, et al. Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers. Mol Psychiatry. 2022;27(2):1256&#x2013;1273. doi: 10.1038/s41380-021-01351-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01351-3</ArticleId><ArticleId IdType="pmc">PMC9054681</ArticleId><ArticleId IdType="pubmed">35087196</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>